Business Description
ZeroStack Corp., based in Toronto, Canada, operates through its German subsidiary Phatebo GmbH to distribute a wide range of medicines and medical products across Germany, covering treatment areas such as cancer, ADHD, multiple sclerosis, and depression. Alongside this, the company manages a portfolio focused on artificial intelligence infrastructure, holding 0G tokens as a core asset while also providing funding to early-stage businesses. Originally founded in 2019 under the name Flora Growth Corp., the company rebranded to ZeroStack Corp. in January 2026.
